9-Ethylcarbazole (N-Ethylcarbazole) serves as a hydrogen storage material. The introduction of nitrogen (N) into 9-ethylcarbazole can reduce the endothermic nature of the reaction and decrease the dehydrogenation temperature, thereby facilitating the process of hydrogen storage and release[1].

9-Ethylcarbazole (N-Ethylcarbazole) serves as a hydrogen storage material. The introduction of nitrogen (N) into 9-ethylcarbazole can reduce the endothermic nature of the reaction and decrease the dehydrogenation temperature, thereby facilitating the process of hydrogen storage and release[1].

9-Ethylguanine is a modified nucleobase derived from guanine and utilized to investigate the antitumor activity of organometallic complex[1].

9-HETE, a monohydroxy fatty acid, is the lipoxygenase metabolite of arachidonic acid (HY-109590)[1].

9-Nitrooleate is a nitrated fatty acid that is formed through NO-dependent oxidation. 9-Nitrooleate has the potential for vascular diseases research[1].

9-OAHSA is a fatty acid ester of hydroxy fatty acids (FAHFAs). 9-OAHSA shows anti-inflammatory effects via inhibiting cytokine production and reduces IL-1β and IL-6 expression. 9-OAHSA is also a protective molecule to prevent colon carcinoma cells from apoptotic cell death[1][2][3].

9-OxoOTrE (9-KOTrE) is an antifungal agent against B. cinerea, C. herbarum, P. infestans, and P. parasitica, through a mechanism based on their electrophilic nature[1].

9-POHSA is a fatty acid ester of hydroxy fatty acids (FAHFAs). 9-POHSA shows anti-inflammatory effects via inhibiting cytokine production and reduces IL-1β and IL-6 expression[1][2].

9-Propenyladenine (Standard) is the analytical standard of 9-Propenyladenine. This product is intended for research and analytical applications. 9-Propenyladenine is a mutagenic impurity in tenofovir disoproxil fumarate. Tenofovir is an antiretroviral agent known as nucleotide analogue reverse transcriptase inhibitors, which block reverse transcriptase, a crucial virus enzyme in HIV-1 and HBV.

9-SAHSA is a fatty acid ester of hydroxy fatty acids (FAHFAs). 9-SAHSA is a protective molecule to prevent colon carcinoma cells from apoptotic cell death[1][2].

9(E),11(E)-Octadecadienoic acid is an isomer of conjugated linoleic acid (CLA). Conjugated linoleic acid is a fatty acid with potentially beneficial physiological and anticarcinogenic effects[1].

9(R)-PAHSA is a R-enantiomer of 9-PAHSA. 9-PAHSA is an orally available anti-inflammatory lipid that lowers blood sugar and reduces inflammation[1][2].

9(S)-HETE is the S isomer of 9-HETE (HY-113943A). 9-HETE, a monohydroxy fatty acid, is the lipoxygenase metabolite of arachidonic acid (HY-109590)[1].

9(S)-PAHSA is a S-enantiomer of 9-PAHSA. 9-PAHSA is an orally available anti-inflammatory lipid that lowers blood sugar and reduces inflammation[1][2].

9(Z),11(Z)-octadecadienoic acid is an isomer of linoleic acid and has antitumor activity (EC 50 = 446.1 µM)[1].

93-O17O is a chalcogen-containing ionizable cationic lipidoid that used in the formation of lipid nanoparticles (LNPs) [1].

9322-O16B, an ionizable cationic lipid, is used for LNP generation[1].

9A1P9 is a multi-tail ionizable cationic phospholipid. 9A1P9 induces membrane destabilization. 9A1P9 can be used for CRISPR-Cas9 gene editing in mice[1].

A-205 is a multifunctional dye. Dyes are important tools in biological experiments. They can help researchers observe and analyze cell structures, track biomolecules, evaluate cell functions, distinguish cell types, detect biomolecules, study tissue pathology and monitor microorganisms. Their applications range from basic scientific research to clinical A wide range of diagnostics. Dyes are also widely […]

A-26771B is an antibiotic can be obtained from Penicillium turbatum. A-26771B exhibits moderate antimicrobial activity against Gram-positive bacteria, mycoplasma, and fungi. A-26771B also inhibits potassium-dependent ATPase in rat liver mitochondria[1].

A1BG Human Pre-designed siRNA Set A contains three designed siRNAs for A1BG gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

A1CF Human Pre-designed siRNA Set A contains three designed siRNAs for A1CF gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

A2AAR/hMAO-B-IN-1 (compoudn 17) is a non-xanthine dual-target inhibitor targeting the A2A adenosine receptor (A2AAR) (IC50: 34.9 nM) andMAO-B (Ki: 39.5 nM, human). A2AAR/hMAO-B-IN-1 inhibits A2AAR-induced cAMP accumulation and exhibits competitive, reversible inhibition of MAO-B. A2AAR/hMAO-B-IN-1 can be used in the study of neurodegenerative diseases such as Parkinson’s disease (PD)[1].

A2AR/A2BR antagonist 1 (compound 7ai) has a dual antagonistic effect on A2AR/A2BR, with the IC50 values of 11.2 nM and 6.4 nM for A2AR and A2BR, respectively. A2AR/A2BR antagonist 1 promotes T cell-mediated cancer cell death[1].

A2M Human Pre-designed siRNA Set A contains three designed siRNAs for A2M gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

A2ML1 Human Pre-designed siRNA Set A contains three designed siRNAs for A2ML1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

A3AR agonist 3 (Compound 15A) is a A3 adenosine receptor (A3AR) agonist, with Ki and EC50 values of 2.27 and 0.20 nM for hA3 and cAMP, respectivelly. A3AR agonist 3 can e used for the research of neuroinflammation[1].

A3AR agonist 4 is an A3 adenosine receptor (A3AR) agonist (Ki: 1.24 nM for hA3AR). A3AR agonist 4 inhibits cAMP production with an EC50 of 0.17 nM. A3AR agonist 4 can be used for research of inflammation and pain[1].

A3AR agonist 5 (Compound 6b) is a A3 adenosine receptor (A3AR) activator, with EC50 and Ki values of 0.14 nM and 6.36 nM for cAMP and hA3, respectively. A3AR agonist 5 can be used in pain and inflammatory research[1].

A3AR antagonist 3 (compound 21) is a selective A3 adenosine receptor (A3AR) antagonist with a Ki of 37 nM. A3AR antagonist 3 shows >60-fold selectivity in comparison to A1 and A2A adenosine receptors[1].

A3GALT2 Human Pre-designed siRNA Set A contains three designed siRNAs for A3GALT2 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

A4GALT Human Pre-designed siRNA Set A contains three designed siRNAs for A4GALT gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

A4GNT Human Pre-designed siRNA Set A contains three designed siRNAs for A4GNT gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

AAAS Human Pre-designed siRNA Set A contains three designed siRNAs for AAAS gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

AACA is an inhibitor for sclerostin, that binds sclerostin on loop3 region with Kd of 15.4 nM. AACA exhibits anti-osteoporosis activity through Wnt signaling pathway[1].

AACS Human Pre-designed siRNA Set A contains three designed siRNAs for AACS gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

AADAC Human Pre-designed siRNA Set A contains three designed siRNAs for AADAC gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

AADAT Human Pre-designed siRNA Set A contains three designed siRNAs for AADAT gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

AAGAB Human Pre-designed siRNA Set A contains three designed siRNAs for AAGAB gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

AAK1 Human Pre-designed siRNA Set A contains three designed siRNAs for AAK1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

Aak1 Mouse Pre-designed siRNA Set A contains three designed siRNAs for Aak1 gene (Mouse), as well as a negative control, a positive control, and a FAM-labeled negative control.

Aak1 Rat Pre-designed siRNA Set A contains three designed siRNAs for Aak1 gene (Rat), as well as a negative control, a positive control, and a FAM-labeled negative control.

AAMDC Human Pre-designed siRNA Set A contains three designed siRNAs for AAMDC gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

AAMP Human Pre-designed siRNA Set A contains three designed siRNAs for AAMP gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

AANAT Human Pre-designed siRNA Set A contains three designed siRNAs for AANAT gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

AAR2 Human Pre-designed siRNA Set A contains three designed siRNAs for AAR2 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

AARD Human Pre-designed siRNA Set A contains three designed siRNAs for AARD gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.